Jerusalem Post - 1 hour ago AstraZeneca Plc's Pulmicort Respules asthma treatment will compete with a cheaper version from Teva Pharmaceutical Industries Ltd . that may steal as much as 80 percent of sales.The US Food and ...
Milwaukee Business Journal - 3 hours ago
Teva Pharmaceuticals USA Inc . and Barr Laboratories Inc . signed an agreement Wednesday with Aventis Pharmaceuticals Inc . , Sanofi - Aventis and Albany Molecular Research Inc . to settle patent ...
BloggingStocks - 2 hours ago
Teva Pharmaceuticals ( NASDAQ : TEVA - option chain ) shares have moved higher today after the Food & Drug Administration approved the company's generic version Pulmicort , an asthma drug made ...
Forbes - 1 hour ago
Between generic competition and disappointing drug trials , Britain's AstraZeneca is in need of a little tender loving care.The drug maker said Wednesday that the US Food and Drug Administration ...
